CME Presentations

HoFH


Presentations


Speakers

  • Jorge Plutzky, MD

    Jorge Plutzky, MD

    Jorge Plutzky, MD

    Associate Professor of Medicine

  • Christie M. Ballantyne, MD

    Christie M. Ballantyne, MD

    Christie M. Ballantyne, MD

    Professor of Medicine

    Christie M. Ballantyne, MD, is vice chair of research for the Department of Medicine, chief, sections of cardiology and cardiovascular research, and director of the Lipid Metabolism and Atherosclerosis Clinic Center for Cardiometabolic Disease Prevention at Baylor College of Medicine in Houston, Texas. Dr Ballantyne is a leading expert on lipids, atherosclerosis and heart disease prevention. He is an established investigator for the American Heart Association and receives funding from the National Institutes of Health for research and clinical trials. Dr Ballantyne is an editorial director for www.lipidsonline.org, serves on the editorial board for Circulation, and has published extensively on atherosclerosis, lipids and inflammation. He received his MD from Baylor College of Medicine.

CME Information

Homozygous Familial Hypercholesterolemia: A Call to Action to Improve Diagnosis and Management


PIM Logo PQH Logo FNLA Logo ASPC Logo

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to:
  • Recognize the signs and symptoms of HoFH based on examination findings, low-density lipoprotein cholesterol (LDL-C) levels, and information from clinical and family histories
  • Apply current guidelines for the management of HoFH, in terms of LDL-C targets and therapeutic approaches to LDL-C reduction
  • Explain how, when added to conventional therapies, investigational agents with novel mechanisms of action or formulations can help reach LDL-C target goals and reduce non-LDL particles, while reducing the need for apheresis in adults and children
Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC working in collaboration with the American Society for Preventive Cardiology (ASPC), and the Familial Hypercholesterolemia (FH) Foundation.

ACKNOWLEDGEMENT

Supported by an educational grant from Novartis and Regeneron.

TUITION

Complimentary

JointlyAccreditedProvider Logo

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

LIVE CREDIT DESIGNATION STATEMENT

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ENDURING CREDIT DESIGNATION STATEMENT

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION

Live Activity

Tuesday, July 20, 2021 at 2:00-3:00pm EST

Enduring Material

July 20, 2021 – July 20, 2022.

TARGET AUDIENCE

The intended audience for this activity program are cardiologists, PCPs, lipidologists, and endocrinologists.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.CardioCareLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Peter P. Toth, MD, PhD, FCCP, FASPC, FAHA, FESC, FACC
Director of Preventative Cardiology
CGH Medical Center
Sterling, Illinois
Professor of Clinical Family and Community Medicine
University of Illinois College of Medicine
Peoria, Illinois
Professor of Clinical Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, Michigan
Adjunct Associate Professor Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
President, American Society for Preventive Cardiology
Consulting Fees (e.g advisory boards): Amarin, bio89, Kowa, Novartis, and Theravance

Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g speakers’ bureaus): Amgen, Esperion, Mereck, Novo-Nordisk
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, FACP, FCCP
Harvard Medical School
Executive Director
Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart and Vascular Center
Boston, MA
Contracted Research: Abbott, Afimmune, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CSL Behring, Eisai, Ethicon, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Lexicon, Lilly, Medtronic, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Regeneron, Roche, Sanofi, Synaptic, The Medicines Company, and 89Bio

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Carole Drexel
Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Bridget Griffin, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support: Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com.